180 related articles for article (PubMed ID: 24888839)
1. HB-EGF augments the ability of mesenchymal stem cells to attenuate intestinal injury.
Watkins DJ; Zhou Y; Matthews MA; Chen L; Besner GE
J Pediatr Surg; 2014 Jun; 49(6):938-44; discussion 944. PubMed ID: 24888839
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of HB-EGF and mesenchymal stem cells in a murine model of intestinal ischemia/reperfusion injury.
Watkins DJ; Yang J; Matthews MA; Besner GE
J Pediatr Surg; 2013 Jun; 48(6):1323-9. PubMed ID: 23845626
[TBL] [Abstract][Full Text] [Related]
3. Heparin-binding epidermal growth factor-like growth factor protects mesenchymal stem cells.
Watkins DJ; Zhou Y; Chen CL; Darbyshire A; Besner GE
J Surg Res; 2012 Oct; 177(2):359-64. PubMed ID: 22658491
[TBL] [Abstract][Full Text] [Related]
4. Heparin-binding epidermal growth factor-like growth factor and mesenchymal stem cells act synergistically to prevent experimental necrotizing enterocolitis.
Yang J; Watkins D; Chen CL; Bhushan B; Zhou Y; Besner GE
J Am Coll Surg; 2012 Oct; 215(4):534-45. PubMed ID: 22819639
[TBL] [Abstract][Full Text] [Related]
5. Heparin-binding epidermal growth factor-like growth factor gene disruption is associated with delayed intestinal restitution, impaired angiogenesis, and poor survival after intestinal ischemia in mice.
El-Assal ON; Paddock H; Marquez A; Besner GE
J Pediatr Surg; 2008 Jun; 43(6):1182-90. PubMed ID: 18558204
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of endogenous heparin-binding EGF-like growth factor (HB-EGF) expression after intestinal ischemia/reperfusion injury.
Xia G; Rachfal AW; Martin AE; Besner GE
J Invest Surg; 2003; 16(2):57-63. PubMed ID: 12746188
[TBL] [Abstract][Full Text] [Related]
7. Mice overexpressing the gene for heparin-binding epidermal growth factor-like growth factor (HB-EGF) have increased resistance to hemorrhagic shock and resuscitation.
Zhang HY; Radulescu A; Chen CL; Olson JK; Darbyshire AK; Besner GE
Surgery; 2011 Feb; 149(2):276-83. PubMed ID: 20965535
[TBL] [Abstract][Full Text] [Related]
8. Heparin-binding epidermal growth factor-like growth factor (HB-EGF) protected intestinal ischemia-reperfusion injury through JNK and p38/MAPK-dependent pathway for anti-apoptosis.
Ming YC; Chao HC; Chu SM; Luo CC
Pediatr Neonatol; 2019 Jun; 60(3):332-336. PubMed ID: 30455099
[TBL] [Abstract][Full Text] [Related]
9. Heparin-binding EGF-like growth factor decreases inflammatory cytokine expression after intestinal ischemia/reperfusion injury.
Rocourt DV; Mehta VB; Besner GE
J Surg Res; 2007 May; 139(2):269-73. PubMed ID: 17291530
[TBL] [Abstract][Full Text] [Related]
10. Timing, route, and dose of administration of heparin-binding epidermal growth factor-like growth factor in protection against intestinal ischemia-reperfusion injury.
Martin AE; Luquette MH; Besner GE
J Pediatr Surg; 2005 Nov; 40(11):1741-7. PubMed ID: 16291163
[TBL] [Abstract][Full Text] [Related]
11. HB-EGF protects the lungs after intestinal ischemia/reperfusion injury.
James IA; Chen CL; Huang G; Zhang HY; Velten M; Besner GE
J Surg Res; 2010 Sep; 163(1):86-95. PubMed ID: 20599214
[TBL] [Abstract][Full Text] [Related]
12. Heparin-binding epidermal growth factor-like growth factor restores Wnt/β-catenin signaling in intestinal stem cells exposed to ischemia/reperfusion injury.
Chen CL; Yang J; James IO; Zhang HY; Besner GE
Surgery; 2014 Jun; 155(6):1069-80. PubMed ID: 24856127
[TBL] [Abstract][Full Text] [Related]
13. Heparin-binding EGF-like growth factor and enteric neural stem cell transplantation in the prevention of experimental necrotizing enterocolitis in mice.
Wei J; Zhou Y; Besner GE
Pediatr Res; 2015 Jul; 78(1):29-37. PubMed ID: 25806717
[TBL] [Abstract][Full Text] [Related]
14. Heparin-binding EGF-like growth factor protects pericytes from injury.
Yu X; Radulescu A; Chen CL; James IO; Besner GE
J Surg Res; 2012 Jan; 172(1):165-76. PubMed ID: 20863525
[TBL] [Abstract][Full Text] [Related]
15. Heparin-binding EGF-like growth factor downregulates expression of adhesion molecules and infiltration of inflammatory cells after intestinal ischemia/reperfusion injury.
Xia G; Martin AE; Besner GE
J Pediatr Surg; 2003 Mar; 38(3):434-9. PubMed ID: 12632363
[TBL] [Abstract][Full Text] [Related]
16. Heparin-binding epidermal growth factor-like growth factor and intestinal ischemia-reperfusion injury.
El-Assal ON; Besner GE
Semin Pediatr Surg; 2004 Feb; 13(1):2-10. PubMed ID: 14765365
[TBL] [Abstract][Full Text] [Related]
17. Human mesenchymal stromal cells decrease mortality after intestinal ischemia and reperfusion injury.
Markel TA; Crafts TD; Jensen AR; Hunsberger EB; Yoder MC
J Surg Res; 2015 Nov; 199(1):56-66. PubMed ID: 26219205
[TBL] [Abstract][Full Text] [Related]
18. Heparin-binding epidermal growth factor-like growth factor protects rat intestine from ischemia/reperfusion injury.
Pillai SB; Hinman CE; Luquette MH; Nowicki PT; Besner GE
J Surg Res; 1999 Dec; 87(2):225-31. PubMed ID: 10600353
[TBL] [Abstract][Full Text] [Related]
19. HB-EGF improves intestinal microcirculation after hemorrhagic shock.
Zhang HY; Radulescu A; Chen Y; Besner GE
J Surg Res; 2011 Nov; 171(1):218-25. PubMed ID: 20421109
[TBL] [Abstract][Full Text] [Related]
20. Heparin-binding EGF-like growth factor (HB-EGF) protects the intestines from radiation therapy-induced intestinal injury.
Matthews MA; Watkins D; Darbyshire A; Carson WE; Besner GE
J Pediatr Surg; 2013 Jun; 48(6):1316-22. PubMed ID: 23845625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
